Abstract:Introduction: Kefir grains with efficient proteolytic system is an excellent starter culture for the production of bioactive peptides and milk products. This study explores the casein peptides derived from fermented bovine milk by kefir grains using the peptidomics approaches. The angiotensin converting enzyme (ACE) inhibitory activity of these peptides were also investigated. Methods: After fermentation, peptidomics based on the LC-MS/MS was used to investigate the dynamic profile and the structure specificity of generated peptides. The ACE inhibitory activity of peptides was determined by measuring the amount of hippuric acid (HA) by a spectrophotometer at 228 nm. Results: The results indicated that the cell envelope proteinases (CEPs) were the P I -/P III -type. A total of 122 peptides were identified. The β-casein was preferentially hydrolyzed by kefir grains, and the main hydrolysis regions were f57-93, f132-160 and f192-209. The αs1-, and κ-casein were also hydrolyzed by a weaker degree. In the process of fermentation, the accumulated peptides increased with the fermentation time. The fermentation products exhibited ACE inhibitory activity, and this bioactivity remained 63% after simulated gastrointestinal (GI) digestion in vitro . Additionally, 14 Pro-containing peptides with ACE inhibitory activity were also identified. Conclusion: These results provide new insights and evidence to investigate the bioactive milk peptides generated by kefir grains fermentation, as well as a reference for the development of functional foods.

In Vitro and in Silico Analysis of Dual-Function Peptides Derived from Casein Hydrolysate

Studies on Preparation of ACE Inhibitory Peptides Through Hydrolyzing of Casein by Enzymatic Membrane Reactor

Study on directed enzymatic preparation from casein based on simulated peptide-cut

Identification and Analysis of Transepithelial Transport Properties of Casein Peptides with Anticoagulant and ACE Inhibitory Activities

Analysis And Evaluation Of The Inhibitory Mechanism Of A Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived From Casein Hydrolysate

Production, Analysis and in Vivo Evaluation of Novel Angiotensin-I-converting Enzyme Inhibitory Peptides from Bovine Casein

Quantitative Structure-Activity Relationship Modeling Coupled with Molecular Docking Analysis in Screening of Angiotensin I-Converting Enzyme Inhibitory Peptides from Qula Casein Hydrolysates Obtained by Two-Enzyme Combination Hydrolysis.

Studies on the Preparation of ACE Inhibitory Peptides from Enzymic Hydrolysate of Milk Casein

Novel Angiotensin I-converting Enzyme Inhibitory Peptides from Protease Hydrolysates of Qula Casein: Quantitative Structure-Activity Relationship Modeling and Molecular Docking Study

Identification of a Novel ACE-inhibitory Peptide from Sheep Casein and Evaluation of the Molecular Binding Mechanism

Evaluation of the multifunctional dipeptidyl-peptidase IV and angiotensin converting enzyme inhibitory properties of a casein hydrolysate using cell-free and cell-based assays

Identification of a Novel ACE-inhibitory Peptide from Casein and Evaluation of the Inhibitory Mechanisms.

Value-added Utilization of Yak Milk Casein for the Production of Angiotensin-I-converting Enzyme Inhibitory Peptides

Peptidomics approaches to the discovery and ACE inhibitory effect of casein peptides derived from fermented bovine milk by kefir grains

Yak Milk Casein As Potential Precursor of Angiotensin I-converting Enzyme Inhibitory Peptides Based on in Silico Proteolysis.

The ACE-inhibitory Activity in Vitro of Casein Hydrolysates Subjected to Enzymatic Modification in the Presence of Three Extrinsic Amino Acids

Yak milk casein as a functional ingredient: preparation and identification of angiotensin-I-converting enzyme inhibitory peptides.

Bioactive hydrolysates from casein: Generation, identification, and in silico toxicity and allergenicity prediction of peptides.

An Anticoagulant Peptide from Beta-Casein: Identification, Structure and Molecular Mechanism

Angiotensin-I-converting Enzyme Inhibitory Peptides from Tryptic Hydrolysates of Sodium Caseinate

Modification of Casein Hydrolysate by Alcalase-catalyzed Plastein Reaction and ACE-inhibitory Activity of Modified Products